Vascular access in chemotherapy of locally advanced or advanced soft tissue sarcomas and osteosarcomas
Abstract
Delivering of chemotherapy for locally advanced or advanced soft tissue sarcomas and osteosarcomas patients has become infeasible without providing for pertinent vascular access. A majority of recent chemotherapeutic agents are either vesicants or irritants agents and therefore require special options for their intravascular administration, which provides for the most effective and safest systemic or regional effect. A number of various issues, associated with intravascular drug administration as a part of present sarcoma treatment regimes and providing of long-term vascular access for better quality of life of cancer patients is discussed in this article. Experience and techniques of insertion and maintenance of various types of vascular access systems, performed in N.N. Blokhin Russian Cancer Research Centre, are described in the article. Subcutaneous implantation of port - a totally implantable central venous access device designed for multiple intermittent infusions - is indicated in order to facilitate drug administration, avoiding extravasation, phlebitis and other complications, associated with systemic and regional chemotherapy.
About the Authors
Y. V. Buidenok
N.N. Blokhin Russian Cancer Research Center, Russian Academy ofMedical Sciences
Russian Federation
Russian Federation
A. A. Fedenko
N.N. Blokhin Russian Cancer Research Center, Russian Academy ofMedical Sciences
Russian Federation
Russian Federation
V. Y. Buidenok
N.N. Blokhin Russian Cancer Research Center, Russian Academy ofMedical Sciences
Russian Federation
Russian Federation
G. N. Machak
N.N. Blokhin Russian Cancer Research Center, Russian Academy ofMedical Sciences
Russian Federation
Russian Federation
M. D. Aliev
N.N. Blokhin Russian Cancer Research Center, Russian Academy ofMedical Sciences
Russian Federation
Russian Federation
References
1. Биневич В.М. Пункции и катетеризации в практической медицине. «ЭЛСБИ-СПб». СПб., 2003, 384 с.
2. Буйденок Ю.В., Мещеряков А.А. Имплантируемые портсистемы венозного доступа в онкологии. Вестник интенсивной терапии. 2004, № 3. с. 3-8.
3. Бунятян А.А., Шитиков И.И., Поплавский И.В., Флеров Е.В. Катетеризация вен. Метод, руковод. ВОС ОНМ- EDA, 1998, 35 с.
4. Галтьери И., Деппе И., Сиперли М., Томсон Д. Катетеризация подключичной вены: ультразвуковой контроль позволяет менее опытным врачам добиться лучших результатов. Вестник интенсивной терапии. 2006, № 4, с. 24-30.
5. Егиев В.Н., Щетинин В.В., Трофименко Ю.Г. Полностью имплантируемые системы в медицине. Медпрактика-М. М., 2004, 60 с.
6. Нобель В.Е., Нельсон Б., Сутингко А.Н. УЗИ при неотложных и критических состояниях. Пер. с англ. «Медицинская литература». М., 2009, 227 с.
7. Сухоруков В.П., Бердикян А.С., Эпштейн С.Л. Пункция и катетеризация вен. Традиционные и новые технологии. Пособие для врачей. Санкт-Петербургское медицинское издательство. 2001, 55 с.
8. Bishop L., Dougherty L., Bodenham A. et al. Guidelines on the insertion and management of central venous access devices in adults. Int. J. Lab. Hematol. 2007, v. 29, p. 261-278.
9. Bong J.J., Kite P., Wtlco M.H., McMahon M.J. Prevention of catheter related bloodstream infection by silver iontophoretic central venous catheters: a randomised controlled trial. J. Clin. Pathol. 2003, v. 56, p. 731-735.
10. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann. Intern. Med. 2002, v. 136, p. 792-801.
11. Gault D.T. Extravasation injuries. Br. J. Plast. Surg. 1993, v. 46 (2), p. 91-96.
12. Katoh K.,Sone M.,Nakasato T. Ehara S. A New Method Using J-Type Long Sheath for Implantation of Indwelling Catheters for Trans-femoral Hepatic Arterial Infusion. Radiation Medicine. 2006, V. 24, No. 1, p. 80-83.
13. Kerr D.J., McArdle C.S. Regional Chemotherapy: Theory and Practice. Informa Healthcare. 01/2000, 120 pages, English.
14. Koldehoff M.,Zakrzewski J.L. Taurolidine is effective in the treatment of central venouscatheter-related bloodstream infectionsin cancer patients Int. J. of Antimicrobial Agents. 24 (2004) p. 491-495.
15. Marshall L., Lloyd G.M. Intravenous fluid filtration. Care of the Critically 111. 1987, v. 3, p. 10-17.
16. McGee D.C., Gould M.K. Preventing Complications of Central Venous Catheterization. The New England Journal ofMedicine. 2003, p. 1123-1133.
17. Registered Nurses’ Association of Ontario. Nursing Best Practice Guidelines. Project: Assessment and Device Selection for VascularAccess. Available at: www.mao.org/bestpractices.
18. Rudolph R., Larson D.L. Etiology and treatment of chemotherapeutic agent extravasation injuries: a review. J. Clin. Oncol. 1987, v. 5,p. 1116-1126.
19. Skippen P., Kissoon N. Ultrasound Guidance for Central Vascular Access in the Pediatric Emergency Department. Pediatric Emergency Care. 2007, v. 23, No. 3, p. 203-207.
Review
For citations:
Buidenok Y.V., Fedenko A.A., Buidenok V.Y., Machak G.N., Aliev M.D. Vascular access in chemotherapy of locally advanced or advanced soft tissue sarcomas and osteosarcomas. Bone and soft tissue sarcomas, tumors of the skin. 2010;(1):7-20. (In Russ.)
Views:
74
Email this article 
